{"entity":{"id":"wuxi-apptec","kind":"company","name":"WuXi AppTec","aka":["药明康德"],"tldr":"WuXi AppTec is the contract research and manufacturing giant that makes small molecules, including ADC payloads and linkers, for much of the global cancer pipeline, and the target of the US BIOSECURE Act.","summary":"Founded by Ge Li in Shanghai; discovery chemistry, toxicology, clinical CRO and small-molecule and peptide manufacturing for most large Western pharma; co-founded JW Therapeutics with Juno. Its cell and gene therapy arm WuXi ATU was sold in 2024 to 2025 after the US BIOSECURE Act named WuXi AppTec and WuXi Biologics as companies of concern, the clearest example of geopolitics reshaping oncology supply chains.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.wuxiapptec.com/"},{"label":"BIOSECURE Act (US Congress)","url":"https://www.congress.gov/bill/118th-congress/house-bill/8333"}],"tags":["china"],"related":[],"cancers":[],"sections":["drug-discovery","chemotherapy"],"technologies":[],"targets":[],"drugs":[],"companies":["wuxi-biologics","jw-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["li-ge"],"bottlenecks":["b-manufacturing-cell-therapy","b-regulatory-fragmentation"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Shanghai","country":"CN","companyType":"cro-services","website":"https://www.wuxiapptec.com/","ticker":"603259.SS / 2359.HK","founded":2000,"investors":[],"funding":[]},"route":"/companies/wuxi-apptec/","neighbours":{"section":[{"id":"chemotherapy","kind":"section","name":"Chemotherapy","route":"/fronts/chemotherapy/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"company":[{"id":"jw-therapeutics","kind":"company","name":"JW Therapeutics","route":"/companies/jw-therapeutics/"},{"id":"wuxi-biologics","kind":"company","name":"WuXi Biologics","route":"/companies/wuxi-biologics/"}],"person":[{"id":"li-ge","kind":"person","name":"Ge Li","route":"/people/li-ge/"}],"bottleneck":[{"id":"b-manufacturing-cell-therapy","kind":"bottleneck","name":"Manufacturing cost and time for living and radioactive medicines","route":"/bottlenecks/b-manufacturing-cell-therapy/"},{"id":"b-regulatory-fragmentation","kind":"bottleneck","name":"Regulatory divergence between regions","route":"/bottlenecks/b-regulatory-fragmentation/"}],"drug":[{"id":"relmacabtagene-autoleucel","kind":"drug","name":"Relmacabtagene autoleucel","route":"/drugs/relmacabtagene-autoleucel/"}],"technology":[{"id":"small-molecule-api-synthesis","kind":"technology","name":"Small-molecule API synthesis","route":"/technologies/small-molecule-api-synthesis/"}]}}